BioIVT Email Format

Biotechnology ResearchNew York, United States201-500 Employees

BioIVT is a biotechnology research company headquartered in Woodbury, New York, with 201-500 employees. It operates as a global provider of high-quality biological specimens and value-added services, including human and animal tissues, cell products, blood, and other biofluids, with a focus on control and disease-state samples and the associated clinical data. Formerly BioreclamationIVT, BioIVT serves the precision medicine and drug development research market by supplying donor samples paired with clinical information. The company offers in vitro hepatic modeling solutions and is described as a premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, to support understanding of pharmacokinetics and drug metabolism. In November 2025 BioIVT acquired Cytesbiotech, a Barcelona-based company focused on coordinating the collection, processing, and distribution of high-quality human tissues and cells for biomedical research. In 2026 BioIVT continued to expand its leadership and partnerships, appointing Dr. Auro Nair as Chief Executive Officer in February 2026 and forming a partnership with Seqster PDM, Inc in April 2026 to deploy new offerings across its clinical sample collection network.

Sign up for free to view info

Company overview Employee directory